BEAUTYFARM MED (02373) received non-executive director Li Fangyu increase holding of 52,000 shares.

BEAUTYFARM MED (02373) announced that Ms. Li Fangyu, a non-executive director of the company, has notified the company that as of December 3, 2025, she has increased her equity interest in the company by 52,000 shares of common stock, representing approximately 0.02% of the total issued shares of the company as of the date of the announcement. These shares were acquired through LIFY Management Holdings Limited in the open market. From December 1 to the date of this announcement, Ms. Li has increased her equity interest in the company by a total of 114,500 shares. The increase in shareholding demonstrates her firm belief and confidence in the future development prospects of the group. On December 3, 2025, the company repurchased 74,500 shares of its own stock (share buyback) in the market, with a total transaction amount of approximately HK$1,942,850 at an average price of approximately HK$26.08 per share. From October 15, 2025, to the date of this announcement, the company has repurchased a total of 849,500 shares, with a total consideration of approximately HK$24,636,000. The board of directors of the company believes that the current market price of the shares does not reflect the intrinsic value of the shares and the actual business prospects of the company. The board believes that the share buyback reflects the management's confidence in the long-term value of the company, and is conducive to enhancing the capital market value of the group and the return to shareholders. The share buyback is in line with the overall interests of the company and its shareholders.